Low risk of type-specific carcinogenic HPV re-appearance with subsequent cervical intraepithelial neoplasia grade 2/3

Ana Cecilia Rodríguez, Mark Schiffman, Rolando Herrero, Allan Hildesheim, Concepciõn Bratti, Mark E. Sherman, Diane Solomon, Diego Guillén, Mario Alfaro, Jorge Morales, Martha Hutchinson, Li Cheung, Sholom Wacholder, Robert D. Burk

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Carcinogenic human papillomavirus (HPV) infections are very common after sexual debut and nearly all become undetectable ("clear") within a few years. Following clearance, the long-term risks of type-specific HPV re-appearance and subsequent risk of cervical intraepithelial neoplasia grade 2 or worse (CIN2+) are not well defined. In the 7-year, population-based cohort study in Guanacaste, Costa Rica, we studied how often type-specific carcinogenic HPV infections re-appeared after clearance and how often re-appearance led to CIN2+. We considered 1,740 carcinogenic HPV infections detected by MY09/11 PCR among 2,805 women (18-91 years old, median 34) who were actively followed at 6- or 12-month intervals. We identified women with one or more type-specific HPV infections that cleared and re-appeared and further defined a subgroup of "definite clearance and re-appearance" (≤2 intervening negative results over a period of ≤1 year). We determined the absolute risk of CIN2+ among the different groups. p values are two-sided. Only 7.7% (81/1,052) of HPV-infected women had intervening negative results. Very few (3.7%, 39/1,052) had "definite clearance and re-appearance", of which 5.1% (2/39) subsequently persisted to a diagnosis of CIN2. There were zero CIN3+ lesions. Extremely few women (2/2,805 of women in our cohort) had a type-specific carcinogenic HPV infection clear, re-appear and lead to CIN2+. If confirmed, this argues against vaccination to avoid re-appearance that leads to precursor lesions and against the need of frequent HPV screening after initial negative results.

Original languageEnglish (US)
Pages (from-to)1874-1881
Number of pages8
JournalInternational Journal of Cancer
Volume131
Issue number8
DOIs
StatePublished - Oct 15 2012

Fingerprint

Cervical Intraepithelial Neoplasia
Papillomavirus Infections
Costa Rica
Vaccination
Cohort Studies
Polymerase Chain Reaction

Keywords

  • CIN2+
  • HPV infection epidemiology
  • HPV infection re-appearance
  • risk after re-appearance

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Low risk of type-specific carcinogenic HPV re-appearance with subsequent cervical intraepithelial neoplasia grade 2/3. / Rodríguez, Ana Cecilia; Schiffman, Mark; Herrero, Rolando; Hildesheim, Allan; Bratti, Concepciõn; Sherman, Mark E.; Solomon, Diane; Guillén, Diego; Alfaro, Mario; Morales, Jorge; Hutchinson, Martha; Cheung, Li; Wacholder, Sholom; Burk, Robert D.

In: International Journal of Cancer, Vol. 131, No. 8, 15.10.2012, p. 1874-1881.

Research output: Contribution to journalArticle

Rodríguez, AC, Schiffman, M, Herrero, R, Hildesheim, A, Bratti, C, Sherman, ME, Solomon, D, Guillén, D, Alfaro, M, Morales, J, Hutchinson, M, Cheung, L, Wacholder, S & Burk, RD 2012, 'Low risk of type-specific carcinogenic HPV re-appearance with subsequent cervical intraepithelial neoplasia grade 2/3', International Journal of Cancer, vol. 131, no. 8, pp. 1874-1881. https://doi.org/10.1002/ijc.27418
Rodríguez, Ana Cecilia ; Schiffman, Mark ; Herrero, Rolando ; Hildesheim, Allan ; Bratti, Concepciõn ; Sherman, Mark E. ; Solomon, Diane ; Guillén, Diego ; Alfaro, Mario ; Morales, Jorge ; Hutchinson, Martha ; Cheung, Li ; Wacholder, Sholom ; Burk, Robert D. / Low risk of type-specific carcinogenic HPV re-appearance with subsequent cervical intraepithelial neoplasia grade 2/3. In: International Journal of Cancer. 2012 ; Vol. 131, No. 8. pp. 1874-1881.
@article{6250b39e85b4406b813172607eea9865,
title = "Low risk of type-specific carcinogenic HPV re-appearance with subsequent cervical intraepithelial neoplasia grade 2/3",
abstract = "Carcinogenic human papillomavirus (HPV) infections are very common after sexual debut and nearly all become undetectable ({"}clear{"}) within a few years. Following clearance, the long-term risks of type-specific HPV re-appearance and subsequent risk of cervical intraepithelial neoplasia grade 2 or worse (CIN2+) are not well defined. In the 7-year, population-based cohort study in Guanacaste, Costa Rica, we studied how often type-specific carcinogenic HPV infections re-appeared after clearance and how often re-appearance led to CIN2+. We considered 1,740 carcinogenic HPV infections detected by MY09/11 PCR among 2,805 women (18-91 years old, median 34) who were actively followed at 6- or 12-month intervals. We identified women with one or more type-specific HPV infections that cleared and re-appeared and further defined a subgroup of {"}definite clearance and re-appearance{"} (≤2 intervening negative results over a period of ≤1 year). We determined the absolute risk of CIN2+ among the different groups. p values are two-sided. Only 7.7{\%} (81/1,052) of HPV-infected women had intervening negative results. Very few (3.7{\%}, 39/1,052) had {"}definite clearance and re-appearance{"}, of which 5.1{\%} (2/39) subsequently persisted to a diagnosis of CIN2. There were zero CIN3+ lesions. Extremely few women (2/2,805 of women in our cohort) had a type-specific carcinogenic HPV infection clear, re-appear and lead to CIN2+. If confirmed, this argues against vaccination to avoid re-appearance that leads to precursor lesions and against the need of frequent HPV screening after initial negative results.",
keywords = "CIN2+, HPV infection epidemiology, HPV infection re-appearance, risk after re-appearance",
author = "Rodr{\'i}guez, {Ana Cecilia} and Mark Schiffman and Rolando Herrero and Allan Hildesheim and Concepci{\~o}n Bratti and Sherman, {Mark E.} and Diane Solomon and Diego Guill{\'e}n and Mario Alfaro and Jorge Morales and Martha Hutchinson and Li Cheung and Sholom Wacholder and Burk, {Robert D.}",
year = "2012",
month = "10",
day = "15",
doi = "10.1002/ijc.27418",
language = "English (US)",
volume = "131",
pages = "1874--1881",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "8",

}

TY - JOUR

T1 - Low risk of type-specific carcinogenic HPV re-appearance with subsequent cervical intraepithelial neoplasia grade 2/3

AU - Rodríguez, Ana Cecilia

AU - Schiffman, Mark

AU - Herrero, Rolando

AU - Hildesheim, Allan

AU - Bratti, Concepciõn

AU - Sherman, Mark E.

AU - Solomon, Diane

AU - Guillén, Diego

AU - Alfaro, Mario

AU - Morales, Jorge

AU - Hutchinson, Martha

AU - Cheung, Li

AU - Wacholder, Sholom

AU - Burk, Robert D.

PY - 2012/10/15

Y1 - 2012/10/15

N2 - Carcinogenic human papillomavirus (HPV) infections are very common after sexual debut and nearly all become undetectable ("clear") within a few years. Following clearance, the long-term risks of type-specific HPV re-appearance and subsequent risk of cervical intraepithelial neoplasia grade 2 or worse (CIN2+) are not well defined. In the 7-year, population-based cohort study in Guanacaste, Costa Rica, we studied how often type-specific carcinogenic HPV infections re-appeared after clearance and how often re-appearance led to CIN2+. We considered 1,740 carcinogenic HPV infections detected by MY09/11 PCR among 2,805 women (18-91 years old, median 34) who were actively followed at 6- or 12-month intervals. We identified women with one or more type-specific HPV infections that cleared and re-appeared and further defined a subgroup of "definite clearance and re-appearance" (≤2 intervening negative results over a period of ≤1 year). We determined the absolute risk of CIN2+ among the different groups. p values are two-sided. Only 7.7% (81/1,052) of HPV-infected women had intervening negative results. Very few (3.7%, 39/1,052) had "definite clearance and re-appearance", of which 5.1% (2/39) subsequently persisted to a diagnosis of CIN2. There were zero CIN3+ lesions. Extremely few women (2/2,805 of women in our cohort) had a type-specific carcinogenic HPV infection clear, re-appear and lead to CIN2+. If confirmed, this argues against vaccination to avoid re-appearance that leads to precursor lesions and against the need of frequent HPV screening after initial negative results.

AB - Carcinogenic human papillomavirus (HPV) infections are very common after sexual debut and nearly all become undetectable ("clear") within a few years. Following clearance, the long-term risks of type-specific HPV re-appearance and subsequent risk of cervical intraepithelial neoplasia grade 2 or worse (CIN2+) are not well defined. In the 7-year, population-based cohort study in Guanacaste, Costa Rica, we studied how often type-specific carcinogenic HPV infections re-appeared after clearance and how often re-appearance led to CIN2+. We considered 1,740 carcinogenic HPV infections detected by MY09/11 PCR among 2,805 women (18-91 years old, median 34) who were actively followed at 6- or 12-month intervals. We identified women with one or more type-specific HPV infections that cleared and re-appeared and further defined a subgroup of "definite clearance and re-appearance" (≤2 intervening negative results over a period of ≤1 year). We determined the absolute risk of CIN2+ among the different groups. p values are two-sided. Only 7.7% (81/1,052) of HPV-infected women had intervening negative results. Very few (3.7%, 39/1,052) had "definite clearance and re-appearance", of which 5.1% (2/39) subsequently persisted to a diagnosis of CIN2. There were zero CIN3+ lesions. Extremely few women (2/2,805 of women in our cohort) had a type-specific carcinogenic HPV infection clear, re-appear and lead to CIN2+. If confirmed, this argues against vaccination to avoid re-appearance that leads to precursor lesions and against the need of frequent HPV screening after initial negative results.

KW - CIN2+

KW - HPV infection epidemiology

KW - HPV infection re-appearance

KW - risk after re-appearance

UR - http://www.scopus.com/inward/record.url?scp=84865327920&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865327920&partnerID=8YFLogxK

U2 - 10.1002/ijc.27418

DO - 10.1002/ijc.27418

M3 - Article

VL - 131

SP - 1874

EP - 1881

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 8

ER -